Latest Regulatory Challenges News

Page 1 of 21
Sequoia Financial Group reported a 75.9% jump in operating profit for 1H FY26 despite a net loss after non-operating charges, prompting a cautious dividend cut amid regulatory challenges.
Claire Turing
Claire Turing
23 Feb 2026
Toubani Resources has obtained the crucial environmental permit for its Kobada Gold Project, clearing the way for construction and initiating resettlement activities as planned.
Maxwell Dee
Maxwell Dee
23 Feb 2026
Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.
Ada Torres
Ada Torres
20 Feb 2026
Solvar Limited reported a 5.8% rise in net profit for the half year ending December 2025, driven by strategic asset sales and expanded funding facilities. The company declared both interim and special dividends, signalling confidence despite ongoing regulatory challenges.
Claire Turing
Claire Turing
18 Feb 2026
Smart Parking Limited reported a robust half-year result for December 2025, nearly doubling revenue to $62.6 million and boosting adjusted EBITDA by 85%, driven by its US acquisition and international growth.
Sophie Babbage
Sophie Babbage
17 Feb 2026
ADX Energy has reported encouraging initial flow test results from the Reifling Formation at its Welchau-1 well, confirming the presence of methane gas and potential light oil. Ongoing testing aims to establish sustained production and further reservoir characteristics.
Maxwell Dee
Maxwell Dee
16 Feb 2026
Fiducian Group’s FY2026 half-year results reveal robust growth with a 9% rise in funds under management and a 17% jump in underlying net profit, despite ongoing regulatory challenges.
Claire Turing
Claire Turing
16 Feb 2026
Osteopore Limited has secured an exclusive three-year distribution deal with Medprin Biotech GmbH to broaden its presence in Latin America's craniofacial reconstruction market, tapping into a region poised for significant growth.
Ada Torres
Ada Torres
13 Feb 2026
Minbos Resources has appointed Rob Newbold as Acting CEO following the resignation of Lindsay Reed, while grappling with administrative and shareholder challenges delaying its key phosphate project in Angola.
Maxwell Dee
Maxwell Dee
13 Feb 2026
ASX Limited reported robust half-year results with an 11.2% rise in operating revenue and a steady net profit, while advancing its technology upgrade and responding to regulatory scrutiny.
Claire Turing
Claire Turing
12 Feb 2026
ASX Limited has posted a solid 8.3% increase in net profit for the half-year ending December 2025, while announcing a reduced dividend payout and the planned departure of its CEO. The company is navigating regulatory scrutiny and investing heavily in technology upgrades.
Claire Turing
Claire Turing
12 Feb 2026
MFF Capital Investments reported a 45% drop in net profit for the half year to December 2025 but declared a higher fully franked dividend, marking a milestone in its operational independence and strategic growth.
Claire Turing
Claire Turing
12 Feb 2026